OptimizeRx Acquires CareSpeak to Expand Digital Health Messaging Platform to Direct Patient Engagement

VCBeat (WeChat ID: vcbeat) has learned that OptimizeRx, a digital health information platform for the pharmaceutical industry, recently announced the completion of its acquisition of CareSpeak. CareSpeak is a company specializing in interactive health information services, aiming to improve patient medication adherence and care coordination. This acquisition by OptimizeRx addresses a critical industry need for direct communication between physicians and patients, helping to enhance patient medication adherence, engagement, and health outcomes.

As a condition of the acquisition, CareSpeak will retain its existing team at its headquarters in Somerset, New Jersey. Specific details of the acquisition have not been disclosed.

OptimizeRx, through its network of globally leading electronic health record (EHR) and e-prescribing vendorsDigital Health Information Platform, bridging the communication gap between the pharmaceutical industry and suppliers. Through this acquisition of CareSpeak, this role can be expanded to cover direct communication with patients, thereby improving patient medication adherence, persistence, and affordability. Last year, OptimizeRx achieved record revenue growth.

A recent study indicates that 25% to 50% of patients worldwide fail to adhere to prescribed medication regimens. In the United States alone, this non-adherence results in up to 125,000 deaths annually and accounts for 10% of hospital admissions. The additional healthcare costs attributable to poor patient adherence amount to $289 billion per year.

Clinical studies have demonstrated that CareSpeak’s existing automated patient engagement platform can significantly improve treatment outcomes, extending the average duration of specialty medication use by 3.5 months. Published data indicate that CareSpeak-supported interventions reduce monthly healthcare costs by $140 per member.

Serge Loncar, CEO of CareSpeak, stated, “The prerequisite for any effective patient adherence and support program is to enable patients to engage in their treatment simply and effortlessly. CareSpeak’s mission is to deliver the right information to patients at the right time, helping them complete their full course of treatment. OptimizeRx enables physicians to convey the right information to both healthcare professionals (HCPs) and patients simultaneously at the point of prescribing. This ‘educational moment’ will have a significant impact on enhancing the patient experience, thereby improving patient adherence and ultimately leading to better outcomes.”

Additional details regarding this acquisition will be filed by OptimizeRx with the U.S. Securities and Exchange Commission (SEC) on Form 8-K.

OptimizeRx, founded in 2006 and headquartered in Michigan, USA, primarily operates a digital health information exchange platform for consumers and physicians to help patients access better treatment plans and improve their adherence. OptimizeRx filed for its initial public offering (IPO) on May 2, 2008.